Description
Release form
Dragee
Packaging
21 pcs
Pharmacological action
Minisiston has an estrogen-progestogen, contraceptive effect. Levonorgestrel in combination with ethinyl estradiol blocks the release of releasing factors (luteinizing and follicle-stimulating) hypothalamus, inhibits the secretion of pituitary gonadotropic hormones, and thus inhibits ovulation increases the viscosity of mucus in the cervix, which makes it difficult for spermatozoa to enter the floor. With regular use, it normalizes the menstrual cycle and helps to prevent a number of gynecological diseases, including tumor nature.
Indications
Contraception, functional disorders of the menstrual cycle, dysmenorrhea.
Contraindications
Hypersensitivity,
pregnancy,
hormone-dependent tumors of the mammary gland or uterus,
severe dysfunction and tumors of the liver,
diabetes mellitus with vascular complications,
thromboembolism ,
arterial hypertension (severe).
Use during pregnancy and lactation
Contraindicated in pregnancy.
Special instructions
Cautiously prescribed to patients with varicose veins, phlebitis, multiple sclerosis, epilepsy, endometriosis, liver diseases. Reception should be stopped and consult a doctor if you first experience migraine-like headaches, acute visual impairment, pregnancy, acute thrombosis, stagnation of bile or jaundice, a significant increase in blood pressure.
Composition
1 tablet contains: levonorgestrel 125 ?g and ethinyl estradiol 30 ?g
Dosage and administration of
minisiston is taken orally. For contraception – 1 tablet per day (the interval between successive doses should not exceed 36 hours) for 21 days, then a 7-day break and a new cycle.
For functional disorders, the doctor selects the dose.
Side effects
In rare cases, headache, depression, nausea, diarrhea, tenderness of the mammary glands with prolonged use, very rarely – chloasma, worsening tolerance of contact lenses.
Storage conditions
In the dark place, at a temperature not exceeding 25 ° C.
Expiration
5 years.
Conditions of supply of pharmacies
Prescription
Prescribing
Prescribing Adult, For women detorodnoho age
Indications
For contraception
Possible product names
Minisiston 20 fem 100mkg + 20mkg Tab. poststation X21
MINISISTON 20 FEM DR. No. 21
Minisiston 20 fem dragees x 21
Minisiston 20 fem dragees No. 21
Minisiston 20 fem tablets n / a 0.1mg + 20mkg N21 pack contact ind pack
Bayer Pharma AG, Germany
